Tower Research Capital (TRC)’s Blonder Tongue Laboratories Inc BDR Stock Holding History

Tower Research Capital (TRC)’s Portfolio BDR Stock Details BDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,127	Closed	-$3K	–	7004
2022 Q1	$3K	Buy	5,127 +1,456	+40%	+$784	﹤0.01%	5494
2021 Q4	$2K	Buy	+3,671	New	+$3.46K	﹤0.01%	5762
2015 Q3	–	Sell	-143	Closed	–	–	5034
2015 Q2	$0	Hold	143	–	–	﹤0.01%	5234
2015 Q1	$0	Sell	143 -357	-71%	-$658	﹤0.01%	5105
2014 Q4	$1K	Buy	+500	New	+$873	﹤0.01%	3774

Tower Research Capital (TRC)'s BDR Position: Q2 2022 in Review

Tower Research Capital (TRC) sold out of Blonder Tongue Laboratories Inc (BDR) in Q2 2022, closing a stake of 5,127 shares — an estimated $3K sold.

Tower Research Capital (TRC) first reported a position in BDR in Q4 2014 and held it in 5 quarters. The position peaked at $3K in Q1 2022. 0 funds tracked by Wall St. Rank hold BDR as of Q2 2022.

Tower Research Capital (TRC) reported no remaining Blonder Tongue Laboratories Inc position as of Q2 2022 after selling out during the quarter.
Tower Research Capital (TRC) sold 5,127 Blonder Tongue Laboratories Inc shares in Q2 2022, an estimated $3K.
Tower Research Capital (TRC) first reported a position in Blonder Tongue Laboratories Inc in Q4 2014 and held it in 5 quarters.
Tower Research Capital (TRC)'s Blonder Tongue Laboratories Inc position peaked at $3K in Q1 2022.
0 funds tracked by Wall St. Rank held Blonder Tongue Laboratories Inc as of Q2 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.